The utility of ultrasound-guided central venous cannulation by hand-held ultrasound device

The utility of ultrasound-guided central venous cannulation by hand-held ultrasound device - Central venous cannulation by hand-held ultrasound device; non-inferiority trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000036943

Enrollment

Registered

2019-06-03

Start date

2018-05-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients aged 20-85 years with ASA-PS 1 or 2 who are planed to undergo general anesthesia.

Interventions

Patients undergoing central venous cannulation by hand-held ultrasound device (Vscan Dual Probe, GE Healthcare) Patients undergoing central venous cannulation by ultrasound device (EDGE,Sonosite)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients in regular surgery with ASA-PS 1 or 2, undergoing right internal jugular vein catheter placement under general anesthesia.

Exclusion criteria

Exclusion criteria: Patients with abnormalities or infection on puncture site, abnormalities of right jugular vein and artery including thrombosis, histories of head and neck surgeries or radiation, difficulties of right internal jugular vein imaging, BMI > 35 and severe lung complications.

Design outcomes

Primary

Measure	Time frame
Duration of the procedure from internal jugular vein puncture to confirmation of guidewire placement.	—

Secondary

Measure	Time frame
number of punctures, needle and guidewire visibility, and anatomic visibility.	—

Countries

Japan

Contacts

Public ContactKenji YAMAMOTO

Nayoro City General Hospital Dept. of Anesthesiology

cab55640@yahoo.co.jp01654-3-3101

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026